Assembly Resolution 1056 is a memorializing resolution that asks Governor Kathy Hochul to proclaim March 2026 as Kidney Disease Awareness Month in New York State, in conjunction with National Kidney Month. The resolution is primarily educational and commemorative in nature; it does not create a new program, mandate, or funding stream, but instead uses the Legislature’s voice to highlight chronic kidney disease (CKD), end-stage renal disease (ESRD), and the importance of awareness, screening, and early intervention.
The resolution describes CKD as a progressive condition that can lead to kidney failure and dialysis or transplant, and notes that many people do not know they have the disease until it reaches later stages. It emphasizes the role of laboratory testing, the symptoms that may appear, and the public health burden in New York and nationwide. The measure also points to the disproportionate impact on African Americans, Hispanics, Asians, Pacific Islanders, Native Americans, older adults, and people with diabetes or hypertension, and it references the transplant waiting list and organ donation registry.
In terms of state-law impact, the resolution does not amend the Public Health Law or any other statute. Its effect is symbolic and promotional: if adopted and acted upon by the Governor, it would support public awareness efforts by formally designating March 2026 as Kidney Disease Awareness Month in New York. It also indirectly supports the work of organizations such as the Northeast Kidney Foundation and reinforces existing public health messaging around prevention, screening, and organ donation.
The general sentiment reflected in the text is strongly supportive and public-health oriented. The resolution frames kidney disease as a serious and often underrecognized condition, and it presents awareness month as a way to encourage education, early detection, and community engagement. Because there are no recorded committee transcripts or votes in the provided material, there is no evidence of opposition or divided views in the available record.
The main points of emphasis, rather than controversy, are the disease’s prevalence, its disproportionate effect on minority communities and older adults, and the need for early intervention. Any potential contention would likely be limited to the usual question for commemorative resolutions of whether such proclamations are the best use of legislative attention, but no specific objections appear in the provided history.
This resolution has no direct statutory effect and does not change New York law. It is a nonbinding memorialization urging the Governor to issue a proclamation designating March 2026 as Kidney Disease Awareness Month, thereby supporting public education, screening awareness, and organ-donation outreach. The practical impact is limited to symbolic recognition and promotion of existing health-awareness efforts.
The available text reflects a positive, unanimous public-health sentiment in favor of the resolution. It presents kidney disease awareness as an important and urgent issue, highlights the benefits of early detection and education, and expresses support for community organizations working on the issue. No committee debate, vote record, or dissent is provided, so there is no evidence of opposition in the supplied materials.
No specific contention is shown in the provided record. The resolution is straightforward and noncontroversial on its face, focusing on awareness and education rather than regulation or spending. If any concern were to arise, it would likely be the general objection sometimes raised to commemorative resolutions—that they are symbolic rather than substantive—but no such objection appears in the bill text, transcripts, or voting history provided.